Evidence map›Paper›PMID 37481553›Full record

ArticleBMC medical research methodology2023

Evaluation of Bayesian spatiotemporal infectious disease models for prospective surveillance analysis.

Joanne Kim, Andrew B Lawson, Brian Neelon, Jeffrey E Korte, Jan M Eberth, Gerardo Chowell

Abstract read
In one paragraph

Article in BMC medical research methodology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Joanne KimDepartment of Biomedical Informatics, The Ohio State University, Columbus, OH, USA. Joanne.Kim@osumc.edu.
Andrew B LawsonDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
Brian NeelonDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
Jeffrey E KorteDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
Jan M EberthDepartment of Health Management and Policy, Drexel University, Philadelphia, PA, USA.
Gerardo ChowellDepartment of Population Health Sciences, Georgia State University, Atlanta, GA, USA.

Funding

Ovarian Cancer Survival in African-American WomenR01CA237318 · NCI · EMORY UNIVERSITY · PI LAWSON, ANDREW B., SCHILDKRAUT, JOELLEN M. · 2020 to 2024
$5.9M
Multivariate spatiotemporal models to quantify disparities in COVID-19 health outcomesR21MD016947 · NIMHD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI NEELON, BRIAN · 2022 to 2023
$428k
A Bayesian nonparametric collaborative filtering algorithm to improve health care decisionsR21LM012866 · NLM · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI LENERT, LESLIE A., NEELON, BRIAN · 2018 to 2019
$370k
NCI NIH HHS R01 CA237318NCI NIH HHS R01-CA237318NIMHD NIH HHS R21 MD016947NIMHD NIH HHS R21MD016947NLM NIH HHS R21 LM012866
6 · The paper itself

Abstract

backgroundCOVID-19 brought enormous challenges to public health surveillance and underscored the importance of developing and maintaining robust systems for accurate surveillance. As public health data collection efforts expand, there is a critical need for infectious disease modeling researchers to continue to develop prospective surveillance metrics and statistical models to accommodate the modeling of large disease counts and variability. This paper evaluated different likelihoods for the disease count model and various spatiotemporal mean models for prospective surveillance.

methodsWe evaluated Bayesian spatiotemporal models, which are the foundation for model-based infectious disease surveillance metrics. Bayesian spatiotemporal mean models based on the Poisson and the negative binomial likelihoods were evaluated with the different lengths of past data usage. We compared their goodness of fit and short-term prediction performance with both simulated epidemic data and real data from the COVID-19 pandemic.

resultsThe simulation results show that the negative binomial likelihood-based models show better goodness of fit results than Poisson likelihood-based models as deemed by smaller deviance information criteria (DIC) values. However, Poisson models yield smaller mean square error (MSE) and mean absolute one-step prediction error (MAOSPE) results when we use a shorter length of the past data such as 7 and 3 time periods. Real COVID-19 data analysis of New Jersey and South Carolina shows similar results for the goodness of fit and short-term prediction results. Negative binomial-based mean models showed better performance when we used the past data of 52 time periods. Poisson-based mean models showed comparable goodness of fit performance and smaller MSE and MAOSPE results when we used the past data of 7 and 3 time periods.

conclusionWe evaluate these models and provide future infectious disease outbreak modeling guidelines for Bayesian spatiotemporal analysis. Our choice of the likelihood and spatiotemporal mean models was influenced by both historical data length and variability. With a longer length of past data usage and more over-dispersed data, the negative binomial likelihood shows a better model fit than the Poisson likelihood. However, as we use a shorter length of the past data for our surveillance analysis, the difference between the Poisson and the negative binomial models becomes smaller. In this case, the Poisson likelihood shows robust posterior mean estimate and short-term prediction results.

Indexed as

Communicable DiseasesCOVID-19Bayes TheoremHumansLikelihood FunctionsPandemicsProspective StudiesBayesian spatiotemporal analysisInfectious disease outbreak modelingPublic health surveillance

Identifiers

PMID37481553
PMCPMC10363300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.